The Pre-RELAX-AHF study randomized 232 subjects with AHF to placebo or four doses of relaxin and evaluated early ( 6-24 h Likert scale ) and persistent [ change in visual analogue scale area under the curve ( VAS AUC ) through Day 5 ] dyspnoea relief .
